AP NEWS

Pontine Glioma: Pipeline Review H1 2018 - Focus on Therapeutics Development & Assessment, Key Companies Involved and Drug Profiles - ResearchAndMarkets.com

June 6, 2018

DUBLIN--(BUSINESS WIRE)--Jun 6, 2018--The “Pontine Glioma - Pipeline Review, H1 2018” report has been added to ResearchAndMarkets.com’s offering.

This latest pipeline guide ‘Pontine Glioma - Pipeline Review, H1 2018’, provides comprehensive information on the therapeutics under development for Pontine Glioma (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Pontine Glioma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Pontine Glioma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Phase II, Phase I, Preclinical, Discovery and Unknown stages are 12, 8, 7, 1 and 1 respectively. Similarly, the Universities portfolio in Phase I and Preclinical stages comprises 3 and 1 molecules, respectively.

Key Topics Covered

Introduction Pontine Glioma - Overview Pontine Glioma - Therapeutics Development Pontine Glioma - Therapeutics Assessment Pontine Glioma - Companies Involved in Therapeutics Development Pontine Glioma - Drug Profiles Pontine Glioma - Dormant Projects Pontine Glioma - Product Development Milestones Appendix

Companies Mentioned

AbbVie Inc Apexigen Inc Arog Pharmaceuticals Inc AstraZeneca Plc Boehringer Ingelheim GmbH Bristol-Myers Squibb Co Burzynski Research Institute Inc Celgene Corp DNAtrix Inc Insys Therapeutics Inc Loxo Oncology Inc Medicenna Therapeutics Corp Midatech Pharma Plc Moleculin Biotech Inc NewLink Genetics Corp Novartis AG Ono Pharmaceutical Co Ltd Pfizer Inc PTC Therapeutics Inc Sanofi Sumitomo Dainippon Pharma Co Ltd ZIOPHARM Oncology Inc

For more information about this report visit https://www.researchandmarkets.com/research/jjfx4j/pontine_glioma?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180606005508/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Brain Cancer Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 06/06/2018 04:50 AM/DISC: 06/06/2018 04:50 AM

http://www.businesswire.com/news/home/20180606005508/en

AP RADIO
Update hourly